VF
SER icon

Virtu Financial’s Serina Therapeutics SER Stock Holding History

Virtu Financial’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-816
Closed -$11K – 2204
2023
Q4 		$11K Buy
+816
New +$15K ﹤0.01% 1407
2022
Q4 		– Sell
-585
Closed -$12K – 2227
2022
Q3 		$12K Buy
+585
New +$13.2K ﹤0.01% 1499
2022
Q1 		– Sell
-947
Closed -$36K – 2134
2021
Q4 		$36K Buy
+947
New +$25.6K ﹤0.01% 1415
2020
Q3 		– Sell
-434
Closed -$14K – 1598
2020
Q2 		$14K Buy
+434
New +$12.8K ﹤0.01% 1163

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $486M AUM 59.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.55B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Virtu Financial's SER Position: Q1 2024 in Review

Virtu Financial sold out of Serina Therapeutics (SER) in Q1 2024, closing a stake of 816 shares — an estimated $11K sold.

Virtu Financial first reported a position in SER in Q2 2020 and held it in 4 quarters. The position peaked at $36K in Q4 2021. 13 funds tracked by Wall St. Rank hold SER as of Q1 2024.

  • Virtu Financial reported no remaining Serina Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 816 Serina Therapeutics shares in Q1 2024, an estimated $11K.
  • Virtu Financial first reported a position in Serina Therapeutics in Q2 2020 and held it in 4 quarters.
  • Virtu Financial's Serina Therapeutics position peaked at $36K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.